PH21834A - New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives - Google Patents

New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives

Info

Publication number
PH21834A
PH21834A PH28380A PH28380A PH21834A PH 21834 A PH21834 A PH 21834A PH 28380 A PH28380 A PH 28380A PH 28380 A PH28380 A PH 28380A PH 21834 A PH21834 A PH 21834A
Authority
PH
Philippines
Prior art keywords
triazolo
new
substituted
phthalazine derivatives
phthalazine
Prior art date
Application number
PH28380A
Other languages
English (en)
Inventor
Emilio Occelli
Domenico Barone
Giorgio Tarzia
Adele Giunta
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of PH21834A publication Critical patent/PH21834A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PH28380A 1982-01-18 1983-01-12 New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives PH21834A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18

Publications (1)

Publication Number Publication Date
PH21834A true PH21834A (en) 1988-03-17

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28380A PH21834A (en) 1982-01-18 1983-01-12 New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives

Country Status (20)

Country Link
US (1) US4788186A (hu)
EP (1) EP0085840B1 (hu)
JP (1) JPS58124786A (hu)
KR (1) KR890000184B1 (hu)
AT (1) ATE22562T1 (hu)
AU (1) AU564026B2 (hu)
CA (1) CA1214168A (hu)
DE (1) DE3366494D1 (hu)
DK (1) DK163145C (hu)
ES (1) ES531458A0 (hu)
FI (1) FI81350C (hu)
GR (1) GR78442B (hu)
HU (1) HU193033B (hu)
IE (1) IE55032B1 (hu)
IL (1) IL67697A (hu)
NO (1) NO161674C (hu)
NZ (1) NZ203021A (hu)
PH (1) PH21834A (hu)
PT (1) PT76107A (hu)
ZA (1) ZA83224B (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
AU724076B2 (en) * 1996-07-25 2000-09-14 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype
ATE236904T1 (de) 1996-07-25 2003-04-15 Merck Sharp & Dohme Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren
EP0986562B1 (en) * 1997-05-08 2002-08-07 MERCK SHARP & DOHME LTD. Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
US6303597B1 (en) 1998-01-14 2001-10-16 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
EA002755B1 (ru) * 1998-01-21 2002-08-29 Мерк Шарп Энд Домэ Лимитед Производные триазолопиридазина в качестве лигандов для гамк рецепторов
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
KR20010041234A (ko) 1998-02-25 2001-05-15 더블유. 지. 콜 치환된 1,2,4-트리아졸로[3,4-ａ]피리다진
JP2002504554A (ja) * 1998-02-25 2002-02-12 メルク シャープ エンド ドーム リミテッド 置換１，２，４−トリアゾロ［３，４−ａ］ピリダジン
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
WO2000027849A2 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
JP2004527531A (ja) * 2001-04-10 2004-09-09 メルク　エンド　カムパニー　インコーポレーテッド 癌を治療する方法
EP1496981A2 (en) * 2002-04-08 2005-01-19 Merck & Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
KR101368093B1 (ko) * 2004-09-02 2014-03-14 다케다 게엠베하 트리아졸로프탈라진
BRPI0606379A2 (pt) 2005-01-05 2009-06-23 Nycomed Gmbh triazolftalazinas
EP1874775B1 (en) * 2005-01-05 2012-10-10 Nycomed GmbH Triazolophthalazines as pde2-inhibitors
SG182297A1 (en) 2009-12-31 2012-08-30 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (hu) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
KR840003254A (ko) 1984-08-20
IE830082L (en) 1983-07-18
NZ203021A (en) 1986-05-09
AU564026B2 (en) 1987-07-30
DK17983D0 (da) 1983-01-18
NO830110L (no) 1983-07-19
DE3366494D1 (de) 1986-11-06
DK17983A (da) 1983-07-19
CA1214168A (en) 1986-11-18
AU1055083A (en) 1983-07-28
EP0085840A1 (en) 1983-08-17
JPS58124786A (ja) 1983-07-25
FI81350C (fi) 1990-10-10
FI81350B (fi) 1990-06-29
JPH048428B2 (hu) 1992-02-17
IL67697A0 (en) 1983-05-15
ZA83224B (en) 1983-10-26
FI830100L (fi) 1983-07-19
NO161674B (no) 1989-06-05
HU193033B (en) 1987-08-28
EP0085840B1 (en) 1986-10-01
KR890000184B1 (ko) 1989-03-09
DK163145B (da) 1992-01-27
IL67697A (en) 1990-02-09
DK163145C (da) 1992-06-22
FI830100A0 (fi) 1983-01-12
GR78442B (hu) 1984-09-27
ATE22562T1 (de) 1986-10-15
PT76107A (en) 1983-02-01
US4788186A (en) 1988-11-29
ES8601995A1 (es) 1985-11-01
IE55032B1 (en) 1990-05-09
NO161674C (no) 1989-09-13
ES531458A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
DE3361803D1 (en) Process for the preparation of (2,2)-paracyclophane
IL68680A (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3378208D1 (en) Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds
ZA83772B (en) Substituted thienobenzodiazepinones,processes for the preparations thereof and pharmaceutical compositions containing these compounds
PT79389A (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
PT76110B (en) Process for the preparation of 3,3-dialkyl indoline and 3,3-alkylene-indoline derivatives and of pharmaceutical compositions containing them
DE3368933D1 (en) Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
DE3361151D1 (en) Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
IL69107A (en) 15-hydroxyimino-14-oxo-eburnamenine derivatives,process for their preparation and pharmaceutical compositions containing these compounds
DE3377217D1 (en) Process for the preparation of monobenzoylated 1,4-diaminoanthraquinones
IL65491A (en) 4-oxo-pgi2 derivatives,process for the preparation thereof and pharmaceutical compositions containing them
GB8314158D0 (en) Process for the preparation of 1,1-bisphenyl-2-haloalkan-1-ols
SG88994G (en) Process for the preparation of anti-oxidant compositions.
IL69106A0 (en) E-homo-eburnane derivatives,process for their preparation and pharmaceutical compositions containing these compounds